Annual Accounts Receivable
N/A
01 December 2023
Summary:
Plus Therapeutics annual accounts receivable is not available.PSTV Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
01 September 2024
Summary:
Plus Therapeutics quarterly accounts receivable is not available.PSTV Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PSTV Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Plus Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $0.00(-100.0%) |
| June 2020 | - | $951.00 K(-2.8%) |
| Mar 2020 | - | $978.00 K(-16.3%) |
| Dec 2019 | $1.17 M(+556.7%) | $1.17 M(-75.5%) |
| Sept 2019 | - | $4.78 M(+5876.3%) |
| June 2019 | - | $80.00 K(-82.4%) |
| Mar 2019 | - | $455.00 K(+155.6%) |
| Dec 2018 | $178.00 K(+22.8%) | $178.00 K(-59.5%) |
| Sept 2018 | - | $440.00 K(+10.3%) |
| June 2018 | - | $399.00 K(-48.1%) |
| Mar 2018 | - | $769.00 K(+430.3%) |
| Dec 2017 | $145.00 K(-88.3%) | $145.00 K(-37.0%) |
| Sept 2017 | - | $230.00 K(-71.5%) |
| June 2017 | - | $807.00 K(-7.6%) |
| Mar 2017 | - | $873.00 K(-29.7%) |
| Dec 2016 | $1.24 M(+18.1%) | $1.24 M(+35.3%) |
| Sept 2016 | - | $918.00 K(+0.8%) |
| June 2016 | - | $911.00 K(+9.9%) |
| Mar 2016 | - | $829.00 K(-21.2%) |
| Dec 2015 | $1.05 M(-15.4%) | $1.05 M(-7.2%) |
| Sept 2015 | - | $1.13 M(+51.2%) |
| June 2015 | - | $750.00 K(+6.5%) |
| Mar 2015 | - | $704.00 K(-43.4%) |
| Dec 2014 | $1.24 M(-70.1%) | $1.24 M(+133.6%) |
| Sept 2014 | - | $532.00 K(-73.5%) |
| June 2014 | - | $2.00 M(-44.9%) |
| Mar 2014 | - | $3.64 M(-12.4%) |
| Dec 2013 | $4.15 M(+5.8%) | $4.15 M(+58.4%) |
| Sept 2013 | - | $2.62 M(-9.5%) |
| June 2013 | - | $2.90 M(-2.2%) |
| Mar 2013 | - | $2.96 M(-24.6%) |
| Dec 2012 | $3.93 M(+73.7%) | $3.93 M(+168.4%) |
| Sept 2012 | - | $1.46 M(-26.2%) |
| June 2012 | - | $1.98 M(+39.2%) |
| Mar 2012 | - | $1.43 M(-36.9%) |
| Dec 2011 | $2.26 M(+9.0%) | $2.26 M(+14.9%) |
| Sept 2011 | - | $1.97 M(-20.1%) |
| June 2011 | - | $2.46 M(+38.7%) |
| Mar 2011 | - | $1.77 M(-14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $2.07 M(+27.1%) | $2.07 M(+24.6%) |
| Sept 2010 | - | $1.66 M(-35.3%) |
| June 2010 | - | $2.57 M(-4.3%) |
| Mar 2010 | - | $2.69 M(+64.9%) |
| Dec 2009 | $1.63 M(+24.7%) | $1.63 M(-12.1%) |
| Sept 2009 | - | $1.85 M(+23.3%) |
| June 2009 | - | $1.50 M(+23.4%) |
| Mar 2009 | - | $1.22 M(-6.8%) |
| Dec 2008 | $1.31 M(>+9900.0%) | $1.31 M(-41.4%) |
| Sept 2008 | - | $2.23 M(+107.9%) |
| June 2008 | - | $1.07 M(+634.9%) |
| Mar 2008 | - | $146.00 K(+1522.2%) |
| Dec 2007 | $9000.00(-96.0%) | $9000.00(-71.0%) |
| Sept 2007 | - | $31.00 K(-31.1%) |
| June 2007 | - | $45.00 K(-80.7%) |
| Mar 2007 | - | $233.00 K(+3.6%) |
| Dec 2006 | $225.00 K(-72.4%) | $225.00 K(+118.4%) |
| Sept 2006 | - | $103.00 K(-70.1%) |
| June 2006 | - | $344.00 K(-26.5%) |
| Mar 2006 | - | $468.00 K(-42.6%) |
| Dec 2005 | $816.00 K(-5.4%) | $816.00 K(-7.6%) |
| Sept 2005 | - | $883.00 K(+79.8%) |
| June 2005 | - | $491.00 K(-70.4%) |
| Mar 2005 | - | $1.66 M(+92.4%) |
| Dec 2004 | $863.00 K(-33.2%) | $863.00 K(+384.8%) |
| Sept 2004 | - | $178.00 K(-87.8%) |
| June 2004 | - | $1.46 M(+45.6%) |
| Mar 2004 | - | $1.00 M(-22.5%) |
| Dec 2003 | $1.29 M(+4.3%) | $1.29 M(-54.3%) |
| Sept 2003 | - | $2.82 M(+138.0%) |
| June 2003 | - | $1.19 M(-19.2%) |
| Mar 2003 | - | $1.47 M(+18.5%) |
| Dec 2002 | $1.24 M(+167.4%) | $1.24 M(-18.9%) |
| Sept 2002 | - | $1.53 M(-14.0%) |
| June 2002 | - | $1.77 M(+529.4%) |
| Mar 2002 | - | $282.00 K(-39.1%) |
| Dec 2001 | $463.00 K(-33.2%) | $463.00 K(-47.2%) |
| Sept 2001 | - | $877.00 K(+42.1%) |
| June 2001 | - | $617.00 K |
| Dec 2000 | $693.00 K | - |
FAQ
- What is the all time high annual accounts receivable for Plus Therapeutics?
- What is the all time high quarterly accounts receivable for Plus Therapeutics?
What is the all time high annual accounts receivable for Plus Therapeutics?
Plus Therapeutics all-time high annual accounts receivable is $4.15 M
What is the all time high quarterly accounts receivable for Plus Therapeutics?
Plus Therapeutics all-time high quarterly accounts receivable is $4.78 M